Linked Life Data

48887BiochemicalReaction48

Source:http://www.reactome.org/biopax/48887BiochemicalReaction48

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
biopax3:comment
Authored: May, B, 2010-08-06, Edited: May, B, 2010-08-06, Reviewed: Neu-Yilik, G, 2011-05-19, SMG1 phosphorylates UPF1 in vitro and in vivo (Denning et al. 2001, Yamashita et al. 2001, Kashima et al. 2006). Serines 1073, 1078, 1096, and 1116 in isoform 2 (Serines 1084, 1089, 1107, 1127 in isoform 1) are phosphorylated in vitro and phosphorylation at serines 1078 and 1096 has been confirmed in vivo (Yamashita et al. 2001, Ohnishi et al. 2003, Kashima et al. 2006). UPF1 also contains additional serine and threonine residues that could be phosphorylated. SMG8 and SMG9 associate with SMG1 and regulate the kinase activity of SMG1 (Yamashita et al. 2009). The phosphorylation reaction is rate-limiting in nonsense-mediated decay and is therefore regarded as a licensing step (reviewed in Rebbapragada and Lykke-Andersen 2009). Phosphorylation is enhanced by the exon junction complex, which can interact with UPF1 via UPF2 and/or UPF3 (Kashima et al. 2006, Ivanov et al. 2008) or via Y14:Magoh (Ivanov et al. 2008). SMG8 and SMG9 bind SMG1 and regulate its kinase activity (Yamashita et al. 2009, Fernandez et al. 2011).
biopax3:xref
biopax3:dataSource
biopax3:displayName
SMG1 Phosphorylates UPF1 (Enhanced by Exon Junction Complex)
biopax3:eCNumber
2.7.11
biopax3:left
biopax3:participantStoichio...
biopax3:right